Literature DB >> 7701874

Interleukin-1 alpha- and beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities in chronic granulomatous skin conditions.

A A Ahmed1, K Nordlind, M Schultzberg, S Lidén.   

Abstract

Paraformaldehyde-fixed tissue of chronic granulomatous skin conditions, such as cutaneous leishmaniasis, granuloma annulare, leprosy and hidroadenitis, was investigated for the presence of interleukin-1 alpha-, interleukin-1 beta-, interleukin-6- and tumour necrosis factor-alpha-like immunoreactivities among the cellular infiltrates. There was a weak to strong cytoplasmic labelling of plasma cells for interleukin-6 and tumour necrosis factor-alpha at the periphery of the granulomatous mass and around the skin appendages. The interleukin-6-like immunoreactivity seemed to be correlated with the coarseness of the chromatin material of the cells, being more intense with coarse chromatin. The cytoplasmic labelling for interleukin-1 alpha and interleukin-1 beta in the plasma cells was less intense. Epitheloid, Langhans' giant cells and small round cells exhibited a weak to moderate cytoplasmic labelling for interleukin-1 alpha and interleukin-1 beta, whereas the staining intensity for interleukin-6 and tumour necrosis factor-alpha was weak to strong. In addition, there was staining of the stroma in the centre of granuloma with antisera against interleukin-1 alpha, interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha. This area contained few cells, suggesting that the granuloma was in a resolution process. A contribution of interleukin-6 and tumour necrosis factor-alpha to the granulomatous reaction, at least during the maintenance period, is suggested by the occurrence of these cytokines in the skin conditions studied. The findings are also consistent with a suggested role of B cells in the late stages of the granulomatous reaction. In addition, they are in line with the reported declining role of interleukin-1 in the maintenance of granuloma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701874     DOI: 10.2340/0001555574435440

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  7 in total

1.  Molecular characterization of skin microbiota between cancer cachexia patients and healthy volunteers.

Authors:  Wei Li; Lei Han; Pengbo Yu; Chaofeng Ma; Xiaokang Wu; John E Moore; Jiru Xu
Journal:  Microb Ecol       Date:  2014-01-09       Impact factor: 4.552

2.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Association of cytokine gene polymorphism with susceptibility and clinical types of leprosy.

Authors:  A Settin; S Nassar; A Abdel-Latif; R Elbaz; S El-Mongy; Aa Hassan; Am Hassan
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

4.  Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy.

Authors:  P Pignataro; A da Silva Rocha; J A C Nery; A Miranda; A M Sales; H Ferrreira; V Valentim; P N Suffys
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

5.  Increased serum interleukin-6 levels in patients with hidradenitis suppurativa.

Authors:  Haoxiang Xu; Xuemin Xiao; Yanyan He; Xiaofeng Zhang; Chengrang Li; Qiuxia Mao; Xinfeng Wu; Baoxi Wang
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

6.  Unbalanced inflammatory reaction could increase tissue destruction and worsen skin infectious diseases - a comparative study of leishmaniasis and sporotrichosis.

Authors:  F N Morgado; L M V de Carvalho; J Leite-Silva; A J Seba; M I F Pimentel; A Fagundes; M F Madeira; M R Lyra; M M Oliveira; A O Schubach; F Conceição-Silva
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 7.  Human cutaneous B cells: what do we really know?

Authors:  Irina Lerman; Drew C Mitchell; Christopher T Richardson
Journal:  Ann Transl Med       Date:  2021-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.